Intercellular Adhesion Molecule-1 E469K Gene Polymorphism and Coronary Artery Disease in the Chinese Population: a Meta-analysis Involving 3065 Subjects
Overview
Authors
Affiliations
Background: The intercellular adhesion molecule-1 (ICAM-1) E469K gene polymorphism has been implicated in increased coronary artery disease (CAD) susceptibility, but the individual study results are still controversial.
Hypothesis: The ICAM-1 E469K gene polymorphism may be associated with CAD risk.
Methods: The current meta-analysis involving 3065 subjects and 11 separate studies was conducted to explore the relationship between the ICAM-1 E469K gene polymorphism and CAD in the Chinese population. The pooled odds ratio (ORs) for the distribution of K allele frequency of ICAM-1 E469K gene and its corresponding 95% confidence interval (CI) was assessed by random effect model.
Results: The distribution of the K allele frequency was 0.67 for the CAD group and 0.60 for the control group. The pooled OR for the distribution of the K allele frequency of the ICAM-1 E469K gene was 1.32 (95% CI, 1.02-1.72; P(heterogeneity) < 0.00001; inconsistency index I(2) = 81.8%). The association between the ICAM-1 E469K gene polymorphism and CAD in the Chinese population was significant (P = 0.04).
Conclusions: In the Chinese population, the distribution of the K allele frequency of the ICAM-1 E469K gene was indicated to be associated with CAD risk. The K allele of the ICAM-1 E469K gene might predispose to the CAD susceptibility.
Myocardial Infarction and p.Thr174Met Polymorphism: A Meta-Analysis of 7657 Subjects.
Li Y, Wang H, Wang H, Zhang Y Cardiovasc Ther. 2021; 2021:6667934.
PMID: 34025779 PMC: 8112938. DOI: 10.1155/2021/6667934.
ICAM-1 gene rs5498 polymorphism decreases the risk of coronary artery disease.
Liu A, Wan A, Feng A, Rui R, Zhou B Medicine (Baltimore). 2018; 97(40):e12523.
PMID: 30290609 PMC: 6200538. DOI: 10.1097/MD.0000000000012523.
Li Y, Wang H, Wu J, Kim H, Yang X, Geng H J Cell Mol Med. 2017; 22(3):1666-1674.
PMID: 29278292 PMC: 5824379. DOI: 10.1111/jcmm.13443.
Hu P, Dai T, Yu W, Luo Y, Huang S Oncotarget. 2017; 8(32):52594-52603.
PMID: 28881754 PMC: 5581053. DOI: 10.18632/oncotarget.17529.
Li Y, Zhou Y, Gong G, Geng H, Yang X Front Physiol. 2017; 8:108.
PMID: 28280469 PMC: 5322195. DOI: 10.3389/fphys.2017.00108.